Difficulty: Medium
Average Score: 95%
Practice
Which of the following drugs is a class III antiarrhythmic agent that is effective in the acute management of atrial fibrillation or atrial flutter of recent onset?
Correct answer
B
Rationale
In this scenario, the correct answer is B) Ibutilide. Ibutilide is a class III antiarrhythmic agent that is effective in the acute management of atrial fibrillation or atrial flutter of recent onset.
Ibutilide exerts its antiarrhythmic effects by prolonging the cardiac action potential and refractory period, thereby helping to restore normal sinus rhythm in patients with atrial fibrillation or flutter. Its mechanism of action involves blocking the rapid component of the delayed rectifier potassium current (IKr), leading to prolongation of the repolarization phase of the cardiac action potential.
Now, let's analyze why the other options are incorrect:
A) Bretylium: Bretylium is a class II antiarrhythmic agent that is primarily used for the management of ventricular arrhythmias. It is not typically used for the acute management of atrial fibrillation or flutter.
C) Metoprolol: Metoprolol is a beta-blocker, which is classified as a class II antiarrhythmic agent. While beta-blockers are commonly used for rate control in atrial fibrillation, they are not typically used for the acute conversion of atrial fibrillation or flutter.
D) Disopyramide: Disopyramide is a class I antiarrhythmic agent, specifically a class IA antiarrhythmic. It is more commonly used for the management of ventricular arrhythmias and is not typically used for acute management of atrial fibrillation or flutter.
In an educational context, understanding the classification of antiarrhythmic drugs is crucial for healthcare professionals, especially nurses, who may encounter patients with various cardiac arrhythmias. It is essential to know the mechanism of action and appropriate use of each class of antiarrhythmic drugs to provide safe and effective care to patients with cardiac rhythm disturbances.
Ibutilide exerts its antiarrhythmic effects by prolonging the cardiac action potential and refractory period, thereby helping to restore normal sinus rhythm in patients with atrial fibrillation or flutter. Its mechanism of action involves blocking the rapid component of the delayed rectifier potassium current (IKr), leading to prolongation of the repolarization phase of the cardiac action potential.
Now, let's analyze why the other options are incorrect:
A) Bretylium: Bretylium is a class II antiarrhythmic agent that is primarily used for the management of ventricular arrhythmias. It is not typically used for the acute management of atrial fibrillation or flutter.
C) Metoprolol: Metoprolol is a beta-blocker, which is classified as a class II antiarrhythmic agent. While beta-blockers are commonly used for rate control in atrial fibrillation, they are not typically used for the acute conversion of atrial fibrillation or flutter.
D) Disopyramide: Disopyramide is a class I antiarrhythmic agent, specifically a class IA antiarrhythmic. It is more commonly used for the management of ventricular arrhythmias and is not typically used for acute management of atrial fibrillation or flutter.
In an educational context, understanding the classification of antiarrhythmic drugs is crucial for healthcare professionals, especially nurses, who may encounter patients with various cardiac arrhythmias. It is essential to know the mechanism of action and appropriate use of each class of antiarrhythmic drugs to provide safe and effective care to patients with cardiac rhythm disturbances.